Inventor
CROWE JR JAMES E
US36 patents
⚠️ This page may combine multiple inventors who share the name “CROWE JR JAMES E”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UNIV VANDERBILT
26 patentsUS7867497B2Jan 11, 2011
Monoclonal antibodies to respiratory syncytial virus and uses therefor
UNIV VANDERBILT23 citations92
US11345741B2May 31, 2022
Human monoclonal antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
UNIV VANDERBILT6 citations80
US11021533B2Jun 1, 2021
Human Zika virus antibodies and methods of use therefor
UNIV VANDERBILT3 citations73
US12233127B2Feb 25, 2025
Human monoclonal antibodies to a new universal influenza A hemagglutinin head domain epitope
UNIV VANDERBILT0 citations62
US12037384B2Jul 16, 2024
Human monoclonal antibodies against yellow fever virus and uses therefor
UNIV VANDERBILT0 citations62
US12024555B2Jul 2, 2024
Human West Nile virus antibodies and methods of use therefor
UNIV VANDERBILT0 citations62
US11957745B2Apr 16, 2024
Human Japanese Encephalitis Virus antibodies and methods of use therefor
UNIV VANDERBILT0 citations62
US11692023B2Jul 4, 2023
Human zika virus antibodies and methods of use therefor
UNIV VANDERBILT0 citations62
US11992520B2May 28, 2024
Human monoclonal antibodies to Staphylococcal aureus Isd proteins and uses thereof
UNIV VANDERBILT0 citations59
US11939370B2Mar 26, 2024
Pan-ebola virus neutralizing human antibodies and methods of use therefor
UNIV VANDERBILT0 citations59
US12216120B2Feb 4, 2025
Human monoclonal antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
UNIV VANDERBILT1 citations58
US11084869B2Aug 10, 2021
Antibody-mediated neutralization of Marburg virus
UNIV VANDERBILT0 citations58
US11054423B2Jul 6, 2021
Antibody-mediated neutralization of ebolaviruses
UNIV VANDERBILT0 citations58
US12496336B2Dec 16, 2025
Peptide vaccine based on a new universal influenza a hemagglutinin head domain epitope and human monoclonal antibodies binding thereto
UNIV VANDERBILT0 citations57
US11596679B2Mar 7, 2023
Hepatitis C virus gene sequences and methods of use therefor
UNIV VANDERBILT0 citations57
US11524994B2Dec 13, 2022
Antibodies to human respiratory syncytial virus protein F pre-fusion conformation and methods of use therefor
UNIV VANDERBILT0 citations54
US11345743B2May 31, 2022
Antibody-mediated neutralization of chikungunya virus
UNIV VANDERBILT0 citations54
US12188053B2Jan 7, 2025
Human monoclonal antibodies that neutralize pandemic GII.4 noroviruses
UNIV VANDERBILT0 citations53
US12559545B2Feb 24, 2026
Human hendra virus and nipah virus antibodies and methods of use therefor
UNIV VANDERBILT0 citations52
US12534512B2Jan 27, 2026
Human monoclonal antibodies to hantavirus and methods of use therefore
UNIV VANDERBILT0 citations52
US11851478B2Dec 26, 2023
Antibody-mediated neutralization of chikungunya virus
UNIV VANDERBILT0 citations52
US10981979B2Apr 20, 2021
Human monoclonal antibodies to Staphylococcus aureus lukab toxin
UNIV VANDERBILT0 citations47
US10620204B2Apr 14, 2020
Antibody-mediated neutralization of Ebola viruses
UNIV VANDERBILT0 citations47
US10787503B2Sep 29, 2020
Antibody-mediated neutralization of Chikungunya virus
UNIV VANDERBILT0 citations44
US12410241B2Sep 9, 2025
Human monoclonal antibodies to enterovirus D68
UNIV VANDERBILT0 citations41
US11667697B2Jun 6, 2023
Human orthopoxvirus antibodies and methods of use therefor
UNIV VANDERBILT0 citations41
US HEALTH
3 patentsUS5922326AJul 13, 1999
Attenuated respiratory syncytial virus vaccine compositions
US HEALTH109 citations99
US5882651AMar 16, 1999
Attenuated respiratory syncytial virus vaccine compositions
US HEALTH19 citations90
US6284254B1Sep 4, 2001
Immunogenic compositions comprising cold-adapted attenuated respiratory syncytial virus mutants
US HEALTH5 citations71
UNIV NORTH CAROLINA CHAPEL HILL
2 patentsUS10117924B2Nov 6, 2018
Chimeric dengue virus E glycoproteins comprising mutant domain I and domain II hinge regions
UNIV NORTH CAROLINA CHAPEL HILL2 citations66
US9821050B2Nov 21, 2017
Chimeric dengue virus E glycoproteins comprising mutant domain I and domain II hinge regions
UNIV NORTH CAROLINA CHAPEL HILL2 citations66